Cilobamine methanesulfonate

Cilobamine methanesulfonate 是一种具有口服活性的抗抑郁剂和多巴胺/去甲肾上腺素再摄取抑制剂,可提高大鼠肝脏中 Aniline hydroxylase 和细胞色素 P-450 的水平,促进大鼠肝脏肝细胞滑面内质网肥大,增加相对肝脏重量和可回收微粒体蛋白,并产生兴奋和致焦虑作用,但不抑制单胺氧化酶,可用于抑郁症的研究。
产品编号: MS-Z06542 CAS No.: 69429-85-2 分子式: C18H27Cl2NO4S 分子量: 424.38
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

Cilobamine methanesulfonate 是一种具有口服活性的抗抑郁剂和多巴胺/去甲肾上腺素再摄取抑制剂,可提高大鼠肝脏中 Aniline hydroxylase 和细胞色素 P-450 的水平,促进大鼠肝脏肝细胞滑面内质网肥大,增加相对肝脏重量和可回收微粒体蛋白,并产生兴奋和致焦虑作用,但不抑制单胺氧化酶,可用于抑郁症的研究。

生物实验数据

生物活性 Cilobamine methanesulfonate is an orally active antidepressant and dopamine/norepinephrine reuptake inhibitor that elevates hepatic Aniline hydroxylase and cytochrome P-450 levels in rats, promotes smooth endoplasmic reticulum hypertrophy in rat hepatocytes, increases relative liver weight and recoverable microsomal protein, and produces excitatory and anxiogenic effects without inhibiting monoamine oxidase, and can be used for research on depression.
体内研究
(In Vivo)

Cilobamine (3-300 mg/kg;口服;每日 1 次;连续 4 天) methanesulfonate 可剂量依赖性地诱导雄性 Charles River CD 大鼠的肝脏药物代谢酶,在 100 和 300 mg/kg 剂量下所有检测指标均出现显著诱导;在使细胞色素 P-450 和乙基吗啡 N-脱甲基酶活性达到对照组的 200% 时,其效力约比苯巴比妥钠低 12 倍,而在苯胺羟化酶活性方面,其效力约低 14 倍。
Cilobamine (100 mg/kg;口服;每日一次;连续 4 天) methanesulfonate 可诱导雌性 Charles River CD 大鼠肝脏药物代谢酶的表达,并增加其相对肝脏重量,且不会改变可回收的微粒体蛋白含量。

Animal Model: Charles River CD (male, 150-210 g)
Dosage: 3 mg/kg; 10 mg/kg; 30 mg/kg; 100 mg/kg; 300 mg/kg; 100 mg/kg (time-course analysis)
Administration: p.o.; daily; 4 days; daily; up to 4 days (time-course analysis)
Result: Showed no significant changes in ethylmorphine N-demethylase activity, aniline hydroxylase activity, cytochrome P-450 content, relative liver weight, or recoverable microsomal protein compared to controls at 3 mg/kg.
Significantly increased ethylmorphine N-demethylase activity; showed no significant changes in aniline hydroxylase activity, cytochrome P-450 content, relative liver weight, or recoverable microsomal protein compared to controls at 10 mg/kg.
Significantly increased ethylmorphine N-demethylase and aniline hydroxylase activities; showed no significant changes in cytochrome P-450 content or relative liver weight; decreased recoverable microsomal protein compared to controls at 30 mg/kg.
Significantly increased ethylmorphine N-demethylase activity (8.43 nmol HCHO/min/mg microsomal protein), aniline hydroxylase activity (25.94 nmol p-aminophenol/hr/mg microsomal protein), cytochrome P-450 content (0.96 nmol/mg microsomal protein), and relative liver weight (5.25 g/100 g body weight; control: 4.40 g/100 g body weight) compared to controls; showed no change in recoverable microsomal protein compared to controls at 100 mg/kg.
Revealed prominent hypertrophy of the smooth endoplasmic reticulum in hepatocytes at 100 mg/kg.
Showed ethylmorphine N-demethylase activity peaked after 3 doses, aniline hydroxylase activity peaked after 2 doses, and cytochrome P-450 content plateaued after 2 doses, with slight declines in enzyme activities after subsequent doses during time-course analysis at 100 mg/kg.
Significantly increased ethylmorphine N-demethylase activity, aniline hydroxylase activity, cytochrome P-450 content, relative liver weight (5.63 g/100 g body weight), and recoverable microsomal protein (34.97 mg/g liver wet weight) compared to controls at 300 mg/kg.
Animal Model: Charles River CD (female, 150-210 g)
Dosage: 100 mg/kg
Administration: p.o.; daily; 4 days
Result: Significantly increased ethylmorphine N-demethylase activity (3.35 nmol HCHO/min/mg microsomal protein), aniline hydroxylase activity (16.39 nmol p-aminophenol/hr/mg microsomal protein), cytochrome P-450 content (0.67 nmol/mg microsomal protein), and relative liver weight (4.06 g/100 g body weight) compared to controls.
Showed no change in recoverable microsomal protein compared to controls.

化学信息

分子量 424.38
分子式 C18H27Cl2NO4S
CAS No. 69429-85-2

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础